180 related articles for article (PubMed ID: 22236001)
1. Oral administration of immunoglobulin G-enhanced colostrum alleviates insulin resistance and liver injury and is associated with alterations in natural killer T cells.
Adar T; Ben Ya'acov A; Lalazar G; Lichtenstein Y; Nahman D; Mizrahi M; Wong V; Muller B; Rawlin G; Ilan Y
Clin Exp Immunol; 2012 Feb; 167(2):252-60. PubMed ID: 22236001
[TBL] [Abstract][Full Text] [Related]
2. Amelioration of non-alcoholic steatohepatitis and glucose intolerance in ob/ob mice by oral immune regulation towards liver-extracted proteins is associated with elevated intrahepatic NKT lymphocytes and serum IL-10 levels.
Elinav E; Pappo O; Sklair-Levy M; Margalit M; Shibolet O; Gomori M; Alper R; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
J Pathol; 2006 Jan; 208(1):74-81. PubMed ID: 16261527
[TBL] [Abstract][Full Text] [Related]
3. Adoptive transfer of regulatory NKT lymphocytes ameliorates non-alcoholic steatohepatitis and glucose intolerance in ob/ob mice and is associated with intrahepatic CD8 trapping.
Elinav E; Pappo O; Sklair-Levy M; Margalit M; Shibolet O; Gomori M; Alper R; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
J Pathol; 2006 May; 209(1):121-8. PubMed ID: 16482497
[TBL] [Abstract][Full Text] [Related]
4. The gut microbiome as a target for regulatory T cell-based immunotherapy: induction of regulatory lymphocytes by oral administration of anti-LPS enriched colostrum alleviates immune mediated colitis.
Ben Ya'acov A; Lichtenstein Y; Zolotarov L; Ilan Y
BMC Gastroenterol; 2015 Oct; 15():154. PubMed ID: 26518263
[TBL] [Abstract][Full Text] [Related]
5. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
6. Hepatoprotective effect of DT56a is associated with changes in natural killer T cells and regulatory T cells.
Shabat Y; Lichtenstein Y; Zolotarov L; Ben Ya'acov A; Ilan Y
J Dig Dis; 2013 Feb; 14(2):84-92. PubMed ID: 23134214
[TBL] [Abstract][Full Text] [Related]
7. Oral Administration of
Mizrahi M; Ben Ya'acov A; Adar T; Levy Sklair M; Gaska S; Ilan Y
J Med Food; 2019 Dec; 22(12):1189-1198. PubMed ID: 31634046
[TBL] [Abstract][Full Text] [Related]
8. Altered distribution of regulatory lymphocytes by oral administration of soy-extracts exerts a hepatoprotective effect alleviating immune mediated liver injury, non-alcoholic steatohepatitis and insulin resistance.
Khoury T; Ben Ya'acov A; Shabat Y; Zolotarovya L; Snir R; Ilan Y
World J Gastroenterol; 2015 Jun; 21(24):7443-56. PubMed ID: 26139990
[TBL] [Abstract][Full Text] [Related]
9. Dietary factors alter hepatic innate immune system in mice with nonalcoholic fatty liver disease.
Li Z; Soloski MJ; Diehl AM
Hepatology; 2005 Oct; 42(4):880-5. PubMed ID: 16175608
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-17 exacerbates hepatic steatosis and inflammation in non-alcoholic fatty liver disease.
Tang Y; Bian Z; Zhao L; Liu Y; Liang S; Wang Q; Han X; Peng Y; Chen X; Shen L; Qiu D; Li Z; Ma X
Clin Exp Immunol; 2011 Nov; 166(2):281-90. PubMed ID: 21985374
[TBL] [Abstract][Full Text] [Related]
11. Dietary α- and γ-tocopherol supplementation attenuates lipopolysaccharide-induced oxidative stress and inflammatory-related responses in an obese mouse model of nonalcoholic steatohepatitis.
Chung MY; Yeung SF; Park HJ; Volek JS; Bruno RS
J Nutr Biochem; 2010 Dec; 21(12):1200-6. PubMed ID: 20138495
[TBL] [Abstract][Full Text] [Related]
12. NF-κB1 deficiency stimulates the progression of non-alcoholic steatohepatitis (NASH) in mice by promoting NKT-cell-mediated responses.
Locatelli I; Sutti S; Vacchiano M; Bozzola C; Albano E
Clin Sci (Lond); 2013 Feb; 124(4):279-87. PubMed ID: 22970906
[TBL] [Abstract][Full Text] [Related]
13. Norepinephrine regulates hepatic innate immune system in leptin-deficient mice with nonalcoholic steatohepatitis.
Li Z; Oben JA; Yang S; Lin H; Stafford EA; Soloski MJ; Thomas SA; Diehl AM
Hepatology; 2004 Aug; 40(2):434-41. PubMed ID: 15368448
[TBL] [Abstract][Full Text] [Related]
14. Probiotics improve high fat diet-induced hepatic steatosis and insulin resistance by increasing hepatic NKT cells.
Ma X; Hua J; Li Z
J Hepatol; 2008 Nov; 49(5):821-30. PubMed ID: 18674841
[TBL] [Abstract][Full Text] [Related]
15. Hyperimmune bovine colostrum containing lipopolysaccharide antibodies (IMM124-E) has a nondetrimental effect on gut microbial communities in unchallenged mice.
Gore R; Mohsenipour M; Wood JL; Balasuriya GK; Hill-Yardin EL; Franks AE
Infect Immun; 2023 Nov; 91(11):e0009723. PubMed ID: 37830823
[TBL] [Abstract][Full Text] [Related]
16. Biochemical and histological characterisation of an experimental rodent model of non-alcoholic steatohepatitis - Effects of a peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist and a glucagon-like peptide-1 analogue.
Daniels SJ; Leeming DJ; Detlefsen S; Bruun MF; Hjuler ST; Henriksen K; Hein P; Karsdal MA; Brockbank S; Cruwys S
Biomed Pharmacother; 2019 Mar; 111():926-933. PubMed ID: 30841472
[TBL] [Abstract][Full Text] [Related]
17. Induction of regulatory T cells decreases adipose inflammation and alleviates insulin resistance in ob/ob mice.
Ilan Y; Maron R; Tukpah AM; Maioli TU; Murugaiyan G; Yang K; Wu HY; Weiner HL
Proc Natl Acad Sci U S A; 2010 May; 107(21):9765-70. PubMed ID: 20445103
[TBL] [Abstract][Full Text] [Related]
18. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
[TBL] [Abstract][Full Text] [Related]
19. Genetic inactivation of the LIGHT (TNFSF14) cytokine in mice restores glucose homeostasis and diminishes hepatic steatosis.
Herrero-Cervera A; Vinué Á; Burks DJ; González-Navarro H
Diabetologia; 2019 Nov; 62(11):2143-2157. PubMed ID: 31388695
[TBL] [Abstract][Full Text] [Related]
20. Beta-glycosphingolipids improve glucose intolerance and hepatic steatosis of the Cohen diabetic rat.
Zigmond E; Zangen SW; Pappo O; Sklair-Levy M; Lalazar G; Zolotaryova L; Raz I; Ilan Y
Am J Physiol Endocrinol Metab; 2009 Jan; 296(1):E72-8. PubMed ID: 18940939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
